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Background: Artemisia nilagirica (Asteraceae) and Murraya koenigii (Rutaceae) are widely distributed in eastern
region of India. Leaves of Artemisia nilagirica plant are used to treat cold and cough by the local tribal population in
east India. Murraya koenigii is an edible plant previously reported to have an antibacterial activity. Pathogenic strains
of mycobacteria are resistant to most of the conventional antibiotics. Therefore, it is imperative to identify novel
antimycobacterial molecules to treat mycobacterial infection.
Methods: In this study, ethanol, petroleum ether and water extracts of Artemisia nilagirica and Murraya koenigii
were tested for antibacterial activity against Mycobacterium smegmatis and Mycobacterium bovis BCG in synergy
with first line anti-tuberculosis (TB) drugs, and for cytotoxic activities on mouse macrophage RAW264.7 cells.
Antibacterial activity was determined by colony forming unit (CFU) assay. Intracellular survival assay was performed
by infecting RAW264.7 cells with M. smegmatis before and after treatment with plant extracts. Cytotoxity was
checked by MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay. Genotoxicity was studied by
DAPI staining and COMET assay using mouse macrophage RAW264.7 cell line. Cell apoptosis was checked by
Annexin-V/FITC dual staining method. Reactive oxygen species and nitric oxide production was checked by DCFH
staining and Griess reagent, respectively.
Results: Ethanol extracts of A. nilagirica (IC50 300 μg/ml) and M. koenigii (IC50 400 μg/ml) were found to be more
effective against Mycobacterium smegmatis as compared to petroleum ether and water extracts. M. koenigii extract
showed maximum activity against M. bovis BCG in combination with a first line anti-TB drug rifampicin. M. koenigii
leaf extract also exerted more cytototoxic (IC50 20 μg/ml), genotoxic and apoptosis in mouse macrophage RAW
264.7 cell line. Treatment of mouse macrophages with A. nilagirica extract increased intracellular killing of M.
smegmatis by inducing production of reactive oxygen species and nitric oxide.
Conclusions: Ethanol extracts of A. nilagirica and M. koenigii were found to be more effective against mycobacteria.
As compared to A. nilagirica, M. koenigii ethanol extract exhibited significant synergistic antibacterial activity against
M. smegmatis and M. bovis BCG in combination with anti-tuberculosis drug rifampicin, and also showed increased
cytotoxicity, DNA damage and apoptosis in mouse macrophages.
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The expanding bacterial resistance to antibiotics has
become a growing concern worldwide. Mycobacterium
tuberculosis (Mtb), the causative agent of tuberculosis
(TB), infection represents a major health problem glo-
bally. It is estimated that one third of the world’s popula-
tion is infected with TB and 1 in 10 of them is prone to
develop an active TB in their lifetime [1]. Though for
several decades TB was successfully treated with a com-
bination of antibiotics, current vaccine and chemothera-
peutic measures are limited in their efficacy and are
failing to prevent spread of the disease. This problem is
further worsened due to the emergence of multi-drug
resistant (MDR) and extremely drug-resistant (XDR)
Mtb strains that has made most of the front line drugs
ineffective, too often impossible, to cure fatal infections
[2]. MDR-TB is resistant to the major first line anti-TB
drugs isoniazid and rifampicin, while XDR-TB is resistant
to any fluoroquinolone, and at least one of three injectable
second-line drugs (capreomycin, kanamycin, and amika-
cin), in addition to isoniazid and rifampicin. It is thus im-
portant to identify and develop new molecules that can
overcome the limitations of the present drugs and perturb
development of antibiotic resistance by mycobacteria.
Increasing bacterial resistance is prompting resurgence
in research of the antimicrobial role of herbs against re-
sistant strains. A vast number of medicinal plants have
been recognized as valuable resources of natural anti-
microbial compounds [3,4]. Medicinal plant extracts
offer considerable potential for the development of new
agents effective against infections that are currently dif-
ficult to treat [5,6]. Previous studies have shown that
several substances such as peptides, unsaturated long
chain aldehydes, essential oils and alkaloid constituents
of plant extracts have potential therapeutic properties
[7]. Therefore, assessment of such plants remains an in-
teresting and useful task to find new promising agents
against bacterial infections. In case of TB, the first drug
streptomycin was developed in 1947 and later on isonia-
zid, pyrazinamide and ethambutol were introduced, and
then in 1960’s rifampicin, which till today is considered
as the cornerstone of first-line TB drugs. Since then the
development of anti-TB drugs has faltered. In the last
few decades, though a large number of drugs have been
discovered, many of them failed to kill drug resistant bac-
teria effectively. Moreover, mycobacterium has a lipid rich
cell wall, which prevents binding and diffusion of most of
the drugs [8]. Therefore, there is a need to identify mole-
cules that will act directly on the cell wall of mycobacteria
to achieve effective killing.
Artemisia nilagirica, which belongs to family Astera-
ceae, and Murraya koenigii belonging to family Rutaceae
are well distributed in eastern region of India. Previously
the leaf extract of A. nilagirica has been reported withan antibacterial activity [9]. The leaves of this plant are
also used against cold and cough by the local tribal
population in east India. M. koenigii is an edible plant.
Compounds like mahanine, mahanimbicine and mahanim-
bine fromM. koenigii plant are reported to have antibacter-
ial activity against Staphylococcus aureus, Pseudomonas
aeruginosa, Klebsiella pneumoniae, Escherichia coli and
Streptococcus pneumoniae [10,11].
The main objective of this work was to identify plants
with antimycobacterial activity. Here we have screened
several leaf extracts prepared from Eupatorium tripli-
nerve, Nyctanthes arbortristis, Azadirachta indica, Bar-
ringtonia acutangula, Achyranthes aspera, Moringa
oleifera, Artemisia nilagrica, Murraya koenigii, Lantana
camara, Mentha spicata for their antimycobacterial ac-
tivity. These plants were selected on the basis of their
reported edible or medicinal properties by local tribal
population of eastern India. Among them, A. nilagirica
(IC50 300 μg/ml) and M. koenigii (IC50 400 μg/ml) etha-
nol leaf extracts were found to be more effective against
M. smegmatis and M. bovis BCG. Ethanol extract of M.
koenigii showed increased antibacterial activity against
M. bovis BCG in synergy with an anti-TB drug rifampi-
cin. Ex vivo studies showed that A. nilagirica extract is
able to kill intracellular M. smegmatis in macrophages
by inducing the production of reactive oxygen species
(ROS) and nitric oxide (NO). Toxicity studies showed
that M. koenigii ethanol extract exhibit more cytotoxic
and genotoxic activities and also induced more apop-
tosis in mouse macrophage RAW264.7 cell line, which
indicates presence of both antimycobacterial and cyto-
toxic compounds in the extract.
Methods
Preparation of plant extract
All the plants were identified by Dr. Udhab Behera from
Regional Plant Resource Centre, Odisha and these plants
have been deposited in the herbarium at Regional Plant
Resource Centre, Keonjhar, Odisha, India. Leaves of A.
nilagirica (KCCP/2013/AN/102) and M. koenigii (KCCP/
2013/MK/101) were collected from forests of North Odi-
sha region, India. Leaves were first washed thoroughly to
remove impurities, shade dried and then ground to fine
powder. To prepare extract, leaf powder (10 gm dry
weight) was extracted with 50 ml of absolute ethanol and
kept on shaker for 48 hours. The extract was then centri-
fuged at 2300 g (3-30 K, Sigma) for 20 minutes and super-
natant was collected. Solvent was removed with the help
of rotary evaporator and stored at −20°C. Extract was dis-
solved in 1% DMSO (wt/vol) for further use [12].
Cell lines and bacterial culture conditions
Mycobacterium smegmatismc2155 and M. bovis BCG Pas-
teur (ATCC35734) strains were grown in Middlebrook’s
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OADC (Oleic acid–albumin dextrose–catalase) and 0.05%
tween 80 (Merck) at 37°C and 120 rpm. The mouse
macrophage cell line RAW264.7 was cultured in DMEM
supplemented with 10% fetal calf serum (FCS), 1%
penicillin-streptomycin solution, 1% L-glutamine and
HEPES.
In vitro killing assay
To determine the antibacterial activity of plant extracts,
the overnight grown cultures were centrifuged at 2300 g
for 5 minutes, washed with 1X PBS and the pellet was sus-
pended in 7H9 broth medium. Finally the optical density
(O.D.) of the sample was adjusted to 0.1 at 600 nm that
corresponds to 1 × 107 cfu/ml [13]. Various concentrations
of plant extracts were incubated with 4-5 × 105 bacteria in
7H9 media. Medium with bacteria and 1% DMSO only
were used as controls. Bacteria were harvested at 24 h
time point and the number of colony forming units
(CFUs) was assayed by plating serially diluted samples
on 7H9 medium. The colonies were counted after 72 h
and 3 weeks for M. smegmatis and M . bovis BCG,
respectively.
To check the synergistic activity of plant extract and
anti-TB drugs, IC50 values of rifampicin (0.7 μg/ml) and
isoniazid (7.5 μg/ml) were determined by CFU assay and
their synergistic antimycobacterial activity was checked
with different concentrations (200 and 400 μg/ml) of
plant extracts.
Isobologram analysis
Isobologram analysis was performed to check the com-
binational effect of M. koenigii and rifampicin. IC50
values obtained from M.koeingii (400 μg/ml) and rifam-
picin (0.7 μg/ml) were analyzed by joining the data
points with a line. The IC50 value from the combinator-
ial treatment was also plotted on the same plot. Isobolo-
gram analysis considered the data additive if the data
point falls on the line, synergistic interaction appears
below the line, and an antagonistic interaction appears
above the line [14].
Cytotoxic effect of plant extracts on mouse macrophage
RAW264.7
To determine the cytotoxic activity of plant extracts
on macrophages, RAW264.7 in DMEM were grown in
a 96 well plate (10,000 cells per well) at 37°C, 5% CO2
for 24 hours followed by treatment with different
concentrations of plant extracts for another 24 hours.
Cells were washed with 1X PBS before addition of
MTT. To determine the cell viability, MTT at a con-
centration of 0.1 μg/ml was added to the wells and
incubated for 4 hours at 37°C and 5% CO2 in dark
condition. In metabolically active cells, MTT reducedto purple color insoluble formazan crystal. Formazan
crystals were dissolved in dissolving buffer (11gm SDS
in 50 ml of 0.02 M HCl and 50 ml isopropanol). The
absorbance was read at 570 nm in ELISA reader (Bio-
tek, Germany), compared with the untreated cells and
percentage of viable cells was calculated as described
previously [15].Apoptosis assay
The percentage of apoptotic cells was determined by using
an Annexin V-FITC apoptosis detection kit (Sigma) as
described previously [16]. Briefly, 2 × 105 RAW264.7 cells
per well were grown overnight in a six-well culture plate,
treated with various concentrations of plant extracts and
the cells were incubated for another 12 h. The cells were
treated with trypsin, washed three times with Dulbecco’s
phosphate buffer saline (0.1 M, pH 7.4) and 500 μl of 1X
binding buffer was added, followed by 5 μl of annexin V-
FITC and 10 μl of propidium iodide, and then incubated
for 10 min at room temperature in the dark. Untreated
cells were taken as a negative control. Flow cytometry was
performed by analyzing 10,000 gated cells using a FACS-
Calibur flow cytometer and CellQuest software (Becton
Dickinson, USA).Comet assay
The effect of plant extracts on DNA damage was deter-
mined by alkaline single cell electrophoresis (Comet)
assay. In 6-well cell culture plate, 5 × 105 RAW264.7
macrophages per well were treated with M. koenigii
(100 μg/ml) and A. nilagirica (300 μg/ml) extracts for
12 h [17]. These concentrations were found to be effect-
ive against M. smegmatis under in vitro killing assay.
Untreated cells were used as control. Cells were treated
with trypsin and a cell suspension (5000 cells/μl) was
prepared in 1X phosphate-buffered saline (PBS). Then,
10 μl of cell suspension was mixed with 60 μl of 0.5%
low-melting point agarose. A thin smear of cell suspen-
sion was prepared in glass cavity slides (Blue Label Sci-
entifics, Mumbai, India). The agarose was allowed to
solidify in the dark at 4°C for 45 min, and then the slides
were submerged in lysis solution (10 mM Tris, 100 mM
EDTA, 2.5 M NaCl, 1% Triton-X-100, 10% dimethyl
sulfoxide) for 30 min in dark at 4°C. After lysis, the
slides were washed with distilled H2O, transferred to an
electrophoresis unit containing freshly prepared electro-
phoresis buffer (500 mM EDTA, 200 mM NaOH, pH13.0),
left for unwinding of DNA for 45 min, and the cells were
electrophoresed for 15 min at 15 V. The cells were washed
twice with dH2O, fixed with 70% chilled ethanol, and
stained with 0.5 μg of propidium iodide/ml for 15 min in
dark. The slides were dried and observed using a fluores-
cence microscope (Nikon, Japan).
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To examine whether treatment with plant extracts increase
killing efficiency of macrophages, 5 × 105 RAW264.7 cells
were treated with A. nilagirica extract 2 h before and after
M. smegmatis infection at an multiplicity of infection of 10
termed as “pretreated” and post-treated”, respectively as
described previously [13]. Then the cells were washed with
1X PBS and extracellular bacteria were killed by addition
of 20 μg/ml of gentamicin for 1 h. Macrophages infected
with bacteria alone were used as a control. After 6 h incu-
bation period, cells were washed and lysed with 0.5% triton
X-100. The intracellular survival was determined by plating
serially diluted cultures on 7H10 medium and the colonies
were enumerated after 3 days.
Determination of ROS production
Generation of ROS in RAW264.7 was determined by
using 2′, 7′-dichlorofluorescin diacetate (DCFH-DA), a
lipid-permeable non-fluorescent compound that when
oxidized by intracellular ROS in the presence of cellular
esterase, forms the fluorescent compound 2′, 7′-dichloro-
fluorescein (DCF). RAW264.7 cells (2 × 105) were seeded
on 24-well tissue culture plate. After 24 h, the cells were
treated with different concentrations of A. nilagirica.
Untreateded cells were used as control. After 24 h of treat-
ment, media was removed and DMEM containing 10 μM
DCFH-DA was added to the cells and incubated at 37°C
and 5% CO2 for 4 h. Then the DCFH-DA containing
medium was removed and the cells were rinsed with 1X
PBS and the fluorescence intensity of DCF was mea-
sured using 10,000 gated cells by flowcytometer BD
FACS Canto-II and FACS Diva software as described
previously [18].
Determination of NO production
NO production was determined by using Griess reagent.
RAW264.7 cells were treated with different concentra-
tions (100–400 μg/ml) of plant extracts for 24 h. Super-
natant was collected and 100 μl of each of them was
added in triplicate in a 96-well plate. NaNO2 solution
(0–200 μM) was used as a standard. 100 μl/well of the
Griess reagent (6 mg/ml) was added to the samples and
the reaction products were estimated colorimetrically at
550 nm [19].
Statistical analysis
Statistically significant differences between groups were
determined using Mann Whitney test. Significance was
referred as ** for P ≤ 0.0005 and * for P ≤ 0.01.
Results
Antibacterial activity of plant extracts
Several plant leaf extracts, Eupatorium triplinerve, Nyc-
tanthes arbortristis, Azadirachta indica, Barringtoniaacutangula, Achyranthes aspera, Moringa oleifera, Arte-
misia nilagrica, Murraya koenigii, Lantana camara,
Mentha spicata were screened for anti-mycobacterial
activity. These plants were identified by Dr. Udhab Behera,
Regional Plant Resource Centre, Odisha, India. These
plants have been deposited in the herbarium at Regional
Plant Resource Centre, Keonjhar, Odisha, India. Extracts
were prepared using petroleum ether, ethanol and water
solvents. Among above mentioned plants, only ethanol
extracts of A. nilagirica and M. koenigii showed antibac-
terial activity against M. smegmatis, as determined by
CFU assay. However, extracts prepared using petroleum
ether and water did not show any anti-mycobacterial ac-
tivity (data not shown). As shown in Figure 1, ethanol leaf
extracts of M. koenigii and A. nilagirica showed significant
antibacterial activity at 400 μg/ml (P ≤ 0.0005; Figure 1A)
and 200 μg/ml (P ≤ 0.0005; Figure 1C) concentrations
against M. smegmatis, respectively. However, M. bovis
BCG was found to be resistant to both the plant extracts
under similar conditions (Figure 1B and 1D). As the etha-
nol extract showed more antibacterial activity following
experiments were performed with M. koenigii and A. nila-
girica ethanol extracts only.
Synergistic antibacterial activity of plant extracts and
anti-TB drugs
As M. bovis BCG showed resistance to both the plant
extracts, we checked whether addition of anti-TB drugs
rifampicin and isonizid to plant extracts can enhance the
bacterial killing. For this, first IC50 values of rifampicin
and isoniazid against M. smegmatis were determined.
The values were determined as 0.7 μg/ml and 7.5 μg/ml
for rifampicin and isoniazid, respectively (data not shown).
M. smegmatis was incubated with different concentrations
of plant extracts containing rifampicin (0.7 μg/ml) and
isoniazid (7.5 μg/ml). M. koenigii (MK) extract showed
synergistic activity with rifampicin (P ≤ 0.0005, P ≤ 0.01;
Figure 2A) such that no viable bacteria were observed in
presence of rifampicin and 400 μg/ml of M. koenigii ex-
tract, whereas in presence of MK and rifampicin alone
significantly higher bacterial count was observed. Isobolo-
gram analysis showed that the data point for the combin-
ation of M. koenigii (MK) and rifampicin(RIF) falls below
the line, indicating synergistic activity (Figure 2B). No syn-
ergistic activity was observed with isoniazid (Figure 2C).
As MK extract showed synergistic activity with rifampicin,
we checked their activity against M. bovis BCG. No viable
colonies were observed in presence of a combination of
MK and rifampicin, whereas significantly higher bacterial
colonies were observed in presence of MK extract and ri-
fampicin alone (P ≤ 0.01; Figure 2D). In contrast, A. nila-
girica (AN) extract did not show any synergistic activity
with both rifampicin and isoniazid (P ≤ 0.0005, P ≤ 0.01;
Figure 3A and 3B).
Figure 1 Antibacterial activity of M. koenigii and A. nilagirica ethanol leaf extracts against M. smegmatis and M. bovis BCG. 4-5 × 105M.
smegmatis (A,C) and M. bovis BCG (B, D) were incubated with different concentrations of M. koenigii and A. nilagirica ethanol leaf extracts for
24 h in 7H9 medium and the number of colony forming units were counted after 72 h and 3 weeks for M. smegmatis and M.bovis BCG,
respectively by plating serially diluted samples on 7H9 medium. Media containing bacteria alone was used as control. Experiments were
performed in triplicates, means ± the standard deviation (SD) are shown. **,P≤ 0.0005; *,P≤ 0.01.
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mouse macrophages
The cytotoxic effect of plant extracts on macrophages
was determined by MTT assay, which relies on the fact
that metabolically active cells reduce MTT to purple
formazan. As shown in Figure 4, M. koenigii extract ex-
hibited more cytotoxicity such that at 20 μg/ml concen-
tration approximately 50% reduction in cell viability was
observed (P ≤ 0.0005; Figure 4A). In case of A. nilagirica,
50% reduction in cell viability was observed at 500 μg/
ml (Figure 4B). These data indicated that M. koenigii is
more cytotoxic as compared to A. nilagirica.
We also examined the RAW264.7 morphology in a
monolayer culture after treatment with different concen-
trations of plant extracts. Microscopic observations
showed that treatment with 100 μg/ml of M. koenigii ex-
tract disintegrated the cell morohology. In case of A.
nilagirica no distinct morphological changes were ob-
served at same concentration, however cells appeared
slightly rounded at 300 μg/ml concentration (Figure 4C).
For genotoxic studies, RAW264.7 cells were treated
with M. koenigii (100 μg/ml) and A. nilagirica (300 μg/ml)
extracts. Nuclear integrity and DNA damage was studied
by DAPI and comet assays. Nuclear fragmentation andcomet like tail, which implies DNA damage, was observed
in M. koenigii treated macrophages, whereas no such
DNA damage was observed in A. nilagirica treated cells
(Figure 4D and 4E).Cell apoptosis
To examine the nature of cell death, annexin-V-FITC/PI
dual staining assay was performed according to the man-
ufacturer’s instruction. The dual staining method differ-
entiates early apoptotic (annexin-V positive, PI negative),
late apoptotic (both annexin-V and PI positive), necrotic
(only PI positive) and healthy viable cells (both annexin-V
and PI negative) based on the staining pattern. RAW264.7
cells were treated with M. koenigii (10 and 100 μg/ml) and
A. nilagirica (10 and 300 μg/ml) extracts for 24 h. The
data showed that more than 80% cells were viable after
treatment with 10 μg/ml concentration of M. koenigii,
while at 100 μg/ml concentration more than 80% cells
were found to be necrotic (Figure 5A). In comparison,
no apoptosis was observed after treatment with 10 μg/
ml concentration, and significantly less (10%) apoptosis



































Figure 2 Synergistic antibacterial activity of M. koenigii (MK) ethanol leaf extract and first-line anti-TB drugs. (A) M. smegmatis was
incubated with MK extract (200 and 400 μg/ml) alone or in combination with rifampicin (RIF) (0.3 and 0.7 μg/ml) for 24 h. The number of CFUs
were counted after 72 h of incubation. Data showed decreased bacterial count in presence of both MK and RIF. (B) Isobologram analysis of MK
extract and RIF. The data point falls below the line indicating syngergistic activity. (C) M. smegmatis was incubated with MK extract and isoniazid
(INZ) for 24 hours and numbers of CFUs were assayed. (D) M. bovis BCG was incubated with MK extract (200 μg/ml) and rifampicin (RIF) (0.3 μg/ml) for
24 hours and numbers of CFUs were assayed after 3 weeks. Media containing bacteria alone was used as control. NC means no colonies. Experiments
were performed in triplicates, means ± the SD are shown. **,P≤ 0.0005; *,P≤ 0.01.
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macrophages
As A. nilagirica leaf extract was found to be less cyto-
toxic, we treated RAW264.7 cells with A. nilagirica leaf
extract to check the intracellular killing of mycobacter-
ium. We hypothesized that the extract may stimulate
macrophages, which will lead to intracellular killing of
mycobacteria. To study this, cells were infected with M.
smegmatis two hours before and after infection termedFigure 3 Synergistic anti-bacterial activity of A. nilagirica (AN) ethano
incubated with (A) AN extract and rifampicin (RIF) (B) AN extract and isoni
showing no synergism of A. nilagirica with either of the drugs. Media conta
in triplicates, means ± the SD are shown. **,P≤ 0.0005; *,P≤ 0.01.as “pretreated” and post-treated”, respectively. After 6 hour
of treatment we found that the intracellular bacterial bur-
den was significantly less in pretreated cells in compared
to post treated cells (Figure 5B).
Treatment with A. nilagirica extract induce superoxide
radical production in macrophages
Mycobacterium tuberculosis persists in macrophages for
extended period of time. However, upon activationl leaf extract and first-line anti-TB drugs. M. smegmatis was
azid (INZ) for 24 hours and number of CFUs were assayed. Data
ining bacteria alone was used as control. Experiments were performed
Figure 4 Cytotoxic effect of M. koenigii and A. nilagirica extracts on mouse macrophage. RAW264.7 (1 × 104 cells/ml) in DMEM were grown
in a 96 well plate at 37°C, 5% CO2 for 24 hours, followed by treatment with different concentrations of M. koenigii (A) and A. nilagirica (B) extracts
for another 24 hours. Untreated cells were used as control. Cell viability was determined by MTT assay, M. koenigii extract showed more cytotoxic
effect as compared to A. nilagirica ethanol extract. (C) Monolayer images of RAW264.7 cells after treatment with M. koenigii and A. nilagirica
extacts. (D,E) Effect of M. koenigii and A. nilagirica extracts on DNA damage of mouse macrophage. RAW264.7 cells were treated with M. koenigii
(100 μg/ml) and A. nilagirica (300 μg/ml) for 12 h. The effect on DNA damage (D) and nuclear fragmentation (E) was studied by comet assay and
DAPI staining, respectively. Treatment with M. koenigii ethanol extract caused DNA damage and nucleus fragmentation in macrophages.
Untreated cells were used as a control. Experiments were performed in triplicates; means ± the SD are shown. **,P≤ 0.0005.
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duction of superoxide radicals such as ROS, reactive
nitrogen species (RNS) and nitric oxide (NO). It was
observed that treatment with A. nilagirica leaf extract
induced the production of NO (Figure 5C) and ROS
(Figure 5D) as compared to control cells. These results
indicate that the antibacterial activity of A. nilagirica
leaf extract may be due to inducing the oxidative stress
by increasing the production of ROS and NO.
Discussion
Treatment of drug resistant mycobacterial strains has
become a major problem worldwide. The hydrophobic
nature of Mycobacterium tuberculosis cell wall preventsbinding and diffusion of drugs [20]. Moreover, the cell
wall of pathogenic mycobacteria contains many efflux
pumps, which expels the drugs rapidly before they reach
to the site of action [21]. These two, along with several
other factors [22], play a decisive role in the develop-
ment of resistance in mycobacteria. In this study edible
and medicinally important plants, few of them are used
for the treatment of several diseases by local tribal popula-
tions of India, were screened for their anti-mycobacterial
activity. Ethanol extracts prepared from M. koenigii and
A. nilagirica plants showed significant antimycobacterial
activity. Previous studies have reported anti-inflammatory,
anti-bacterial, anti-tumor activities of M. koenigi extracts
[23,24]. Koenimbine, mahanimbine, mahanine and
Figure 5 Apoptosis assay and superoxide production in RAW 264.7 cells. (A) Apoptosis assay using annexin-V FITC/PI dual staining method.
RAW264.7 were treated with M. koenigii and A. nilagirica extacts for 24 h. The percentage of apoptosis was determined by analyzing 10,000 gated
cells using flow cytometry. (B) Intracellular survival of M. smegmatis in A. nilagirica extract treated macrophages. RAW264.7 cells were treated with
different concentrations of A. nilagirica extacts 2 h before (Pretreatment) and after (post-treatment) M. smegmatis infection. The cells were lysed
and intracellular survival was determined 6 h post infection by CFU assay. Data showed decrease in intracellular bacterial survival in pretreated
macrophages. (C) NO production in RAW264.7 treated with different concentrarions of A. nilagirica leaf extract for 24 h (D) ROS production was
determined by DCFH-DA staining using flow cytometry indicating increased ROS production. Experiments were performed in triplicates.
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diarrhea and antibacterial activities [25,26]. A. nilagirica
has been reported to exhibit insecticidal and antibacter-
ial activities [27]. Around 59 compounds were identified
from A. nilagirica which showed an inhibitory activity
against phytopathogens like Xanthomonas campestris,
Pseudomonas syringae, Clavibacter michiganense [28].
In vitro killing assay using ethanol extracts of M. koenigi
and A. nilagirica showed a significant level of inhibition
against M. smegmatis. On the other hand, petroleum ether
and water extracts did not show any antibacterial activity
indicating that antimycobacterial compounds are mainly
present in ethanol extract. The in vitro antibacterial assay
showed that A. nilagirica extract is more active against M.
smegmatis. Previously, phytochemical analysis of A. nila-
girica ethanol extract showed the presence of alkaloids,
phenolic, quinines and saponins, all of which have been
shown to possess antimicrobial activity [28]. Distinct dif-
ferences in the susceptibility to both plant extracts wereobserved. M. smegmatis was found to be more susceptible,
whereas the mycobacterial vaccine strain, M. bovis BCG
showed resistance to both plant extracts. This may due to
structural and compositional differences in the cell wall of
two groups, which limits the diffusion of drugs inside the
bacterial cell. However, treatment with a combination of
rifampicin and M. koenigii extract led to increased killing
of BCG. Rifampicin kills mycobacteria by binding to the
β subunit of the RNA polymerase thus interfere in the
RNA synthesis. So treatment with M. koenigii extract
might have facilitated the transport of rifampicin inside
the mycobacterial cell by altering cell membrane perme-
ability and thereby killing of mycobacteria by inhibiting
RNA synthesis.
Cytotoxic and genotoxic studies showed that M. koenigii
is more toxic to the mouse macrophages. It was found
that with increasing concentrations, percentage of cell
viability decreased. This cytotoxic effect could be due to
presence of alkaloids in the M. koenigii extract. Previous
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nimbicine alkaloids present in M. koenigii extract exhibit
cytotoxic activity against MCF-7, P388 and HeLa cell lines
[11]. This could also be attributed to higher production of
oxygen radicals, disintegration of membrane integrity and
cytoskeletal functions as a result of treatment. Micro-
scopic studies also showed that treatment with M. koenigii
extract disintegrated the cell morphology. Selectivity
index (SI) is calculated as: SI = Ratio of toxicity to activ-
ity = IC50/MIC. For A. nilagirica, SI = 500/200 = 2.5 and
for M. koenigii, SI = 20/400 = 0.05. More SI value indi-
cates more selectivity for bacteria and less cytotoxic for
cell line. Selective index of ethanol extracts of M. koeni-
gii is less than A. nilagirica ethanol extract, which indi-
cates that ethanol extract of M. koenigii is less selective
for M. smegmatis as compared to A. nilagirica and toxic
for RAW264.7 cell line.
The comet assay showed significant increase in tail
length, which manifests DNA damage, after treatment
with M. koenigii extract, whereas treatment with A. nila-
girica did not show any effect. It has been observed that
exposure to plant extracts lead to an increase in DNA
damage and necrosis [29].
No cell apoptosis was observed at the lower dose
(10 μg/ml), whereas treatment with higher dose of M.
koenigii (100 μg/ml) resulted in an increase in the num-
ber of apoptotic cells. In contrast, significantly less apop-
tosis was observed in A. nilagirica extract treated cells.
The increased DNA damage and apoptosis at higher doses
could also be due to increased production of reactive oxy-
gen species (ROS). It has been reported that increased
ROS production caused genotoxic effect in fibroblast cells
[30], which may lead to cell apoptosis.
Since mycobacteria are an intracellular pathogen [31,32],
which resides in phagosomal compartment of macro-
phages, it is important to activate the macrophages or
deliver the therapeutic molecules to the target sites that
would kill the intracellular mycobacteria. Exogenous
addition of A. nilagirica extract found to kill intracellu-
lar M. smegmatis, Macrophages kill mycobacteria by in-
ducing the ROS and NO production. We observed
increased ROS and NO production in macrophages after
treatment with A. nilagirica extract. Hence the observed
killing effect could be due to formation of superoxide radi-
cals and activation of macrophages. Treatment with plant
extract also induces the production of pro-inflammatory
cytokines [33], which activate the cells resulting in an in-
crease in killing efficiency of macrophages.
Conclusions
Here we have shown that ethanol extracts of M. koenigii
and A. nilagirica exhibit high inhibitory potency against
M. smegmatis and that M. koenigii extract in synergy with
rifampicin killed M. bovis BCG efficiently. M. koenigiiextract was found to be more cytotoxic and genotoxic to
mouse macrophages, whereas A. nilagirica extract killed
intracellular mycobacteria without exhibiting any toxic ef-
fect on macrophages. The intracellular killing could be
due to increased ROS and NO production. This will help
in development of natural antimicrobials to decrease the
side effects of synthetic drugs. Investigation on fraction-
ation and characterization of these active compounds
from both plant extracts is under way.
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